Drug Pipeline

Relmacabtagene autoleucel (relma-cel) Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
2
Top Sponsors
Active Studies by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06365671 CAR-T Following ASCT for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (R/R B-NHL)… B-cell Non Hodgkin Lymphoma Recruiting
NCT07077512 Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell Lymphoma Large B Cell Diffuse Lymphoma Recruiting
NCT07326371 Glofitamab Combined With CAR-T Therapy in R/R DLBCL DLBCL - Diffuse Large B Cell Lymphoma Not Yet Recruiting
Sponsors Running Relmacabtagene autoleucel (relma-cel) Trials
Ruijin Hospital (2) Sun Yat-sen University (1)
Disease Areas
Non-Hodgkin Lymphoma (1) Follicular Lymphoma (1) Mantle Cell Lymphoma (1) DLBCL (1)
Get alerts when Relmacabtagene autoleucel (relma-cel) trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free